LINDA DODD: Open Payments
NPI 1578221719 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,685 in 89 payments from 11 companies in 2025. Trend: 2023 $1,425 · 2024 $1,600 · 2025 $1,685
Food & beverage: $1,685
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $373 |
| Otsuka America Pharmaceutical, Inc. | 11 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $196 |
| Alkermes, Inc. | 9 | $190 |
| Janssen Pharmaceuticals, Inc | 9 | $185 |
| Neurocrine BioSciences, Inc. | 10 | $161 |
| Lundbeck LLC | 5 | $124 |
| E.R. Squibb & Sons, L.L.C. | 4 | $100 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
Products named: VRAYLAR, REXULTI, CAPLYTA, ARISTADA, INGREZZA, SPRAVATO, COBENFY, ABILIFY MAINTENA.
Industry payments across IL — which companies pay providers there.
